1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33. doi:10.3322/caac.21708
2. Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329-359. doi:10.6004/jnccn.2021.0012
3. Liu Q, Huang M, Yang J, et al. Association between the number of retrieved lymph nodes and demographic/tumour-related characteristics in colorectal cancer: a systematic review and meta-analysis. BMJ Open. 2023;13(12):e072244. doi:10.1136/bmjopen-2023-072244
4. Yildirim F, Sezak M, Bozbiyik O, Gursoy P, Doganavsargil B. Clinicopathologic determinants of lymph node count and prognostic significance of metastatic lymph node ratio in colorectal cancer. Diagnostics. 2025;15(23):2962. doi:10.3390/diagnostics15232962
5. Pyo JS, Kim JH, Lee SY, Baek TH, Kang DW. Metastatic lymph node ratio (mLNR) is a useful parameter in the prognosis of colorectal cancer: a meta-analysis for the prognostic role of mLNR. Medicina. 2019;55(10): 673. doi:10.3390/medicina55100673
6. Kang JS, Higuchi R, He J, et al. Proposal of the minimal number of retrieved regional lymph nodes for accurate staging of distal bile duct cancer and clinical validation of the three-tier lymph node staging system (AJCC 8th edition). J Hepatobiliary Pancreat Sci. 2020;27(2):75-83. doi:10.1002/jhbp.706
7. Mroczkowski P, Kim S, Otto R, et al. Prognostic value of metastatic lymph node ratio and identification of factors influencing the lymph node yield in patients undergoing curative colon cancer resection. Cancers (Basel). 2024;16(1):218. doi:10.3390/cancers16010218
8. Wang J, Hassett JM, Dayton MT, Kulaylat MN. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg. 2008;12(10):1790-1796. doi:10.1007/s11605-008-0631-3
9. Aslan O, Topcu R, Sezikli İ, Yüksek MA, Perçem AK, Uğur F. Prognostic value of metastatic lymph node ratio and its effect on disease-free survival in colon cancer. Front Oncol. 2025;15:1624798. doi:10.3389/fonc.2025.1624798
10. Occhionorelli S, Andreotti D, Vallese P, et al. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery. World J Surg Oncol. 2018;16:186. doi:10.1186/s12957-018-1486-0
11. Elbaiomy M, Waheed A, Elkhodary T. Prognostic value of lymph node ratio in lymph node-invaded colon cancer. Ann Oncol. 2019;30(Suppl 4): iv34. doi:10.1093/annonc/mdz155.122
12. Parnaby CN, Scott NW, Ramsay G, et al. Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection. Br J Cancer. 2015;113(2): 212–219. doi:10.1038/bjc.2015.211
13. Chen SL, Steele SR, Eberhardt J, et al. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Ann Surg. 2011;253(1):82-87. doi:10.1097/SLA.0b013e3181f9c846
14. Wang J, Kulaylat M, Rockette H, et al. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg. 2009;249(4):559-563. doi:10.1097/SLA.0b013e31819ed6c5
15. Yang Y, Wang Y, Wang Z. Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: a validation study. Front Surg. 2022;9:929576. doi:10.3389/fsurg.2022.929576
16. Derici ST, Ergenç M, Sücüllü İ, Akın ML. Prognostic role of the lymph node ratio in colorectal cancer: a retrospective study. World J Colorectal Surg. 2022;11:94-100. doi:10.5005/jp-journals-10030-1395
17. Karjol U, Jonnada P, Chandranath A, Cherukuru S. Lymph node ratio as a prognostic marker in rectal cancer survival: a systematic review and meta-analysis. Cureus. 2020;12(5):e8047. doi:10.7759/cureus.8047
18. Beirat AF, Amarin JZ, Suradi HH, et al. Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma. Diagn Pathol. 2024;19(1):44. doi:10.1186/s13000-024-01484-2
19. Xie D, Song X, Tong L. Stage migration resulting from inadequate number of examined lymph nodes impacts prognosis in stage II colon cancer after radical surgery. Int J Colorectal Dis. 2021;36(5):959-969. doi: 10.1007/s00384-020-03792-9
20. Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG. Lymph node evaluation and long-term survival in stage II and stage III colon cancer: a national study. Ann Surg Oncol. 2009;16(3):585-593. doi:10.1245/s10434-008-0265-8
21. Duraker N, Çaynak Z, Hot S. The prognostic value of lymph node ratio in patients with node-positive colorectal cancer. Turk J Colorectal Dis. 2017;27:76-83. doi:10.4274/tjcd.83435
22. Hai ZX, Peng D, Li ZW, et al. The effect of lymph node ratio on the surgical outcomes in patients with colorectal cancer. Sci Rep. 2024;14: 17689. doi:10.1038/s41598-024-17689-7
23. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97(3):219-225. doi:10.1093/jnci/dji020